News
Some 25 years ago, a young Parkinson's disease investigator, Robert Hauser, MD, stepped to the podium at an American Academy ...
Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...
A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, ...
18h
MedPage Today on MSNCough Medicine Shows a Hint of Promise in Parkinson's DementiaAmbroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...
Simon Fraser University researchers are using a new approach to brain imaging that could improve how drugs are prescribed to ...
1d
News-Medical.Net on MSNClinical trial examines whether Ambroxol can slow dementia in people with Parkinson'sResearchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...
After presentations to the International Linked Clinical Trials (iLCT), which was set up by Cure Parkinson’s over a decade ...
3d
Asian News International on MSNBrain scan reveals why Parkinson's drugs don't always work: StudyResearchers at Simon Fraser University reveal how brain imaging techniques can explain the inconsistent effects of levodopa ...
Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s ...
Understand Parkinson's disease, its symptoms, and the crucial role of clinical trials in treatment and research, especially for Black Americans.
3don MSNOpinion
Drastic cuts to NIH will halt brain research on the cusp of transformational treatments. These setbacks could derail future ...
A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results